IL1RN and acute myeloid leukemia: Expression levels of IL1RN were reduced in circulating CD34+ progenitors from patients versus healthy controls (Fig. 1c), which was particularly evident in the more undifferentiated FAB categories of AML (M0–M3) (Fig. 1d).